Discussion - Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure.
Topic:
Diabetes, dysglycaemia and metabolic syndrome
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Boehringer Ingelheim/Lilly
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Doctor David Fitchett
St. Michael's Hospital, Toronto (Canada)
18
presentations
0
follower
Professor John Eric Deanfield
University College London, London (United Kingdom of Great Britain & Northern Ireland)
50
presentations
3
followers
4 more presentations in this session
Introduction - Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure.
Speaker: Doctor D. Fitchett (Toronto, CA)
SGLT2 inhibition in cardiology: what a cardiologist needs to know.
Speaker: Professor N. Sattar (Glasgow, GB)
Management of CV risk & type 2 diabetes mellitus (T2DM): implications of novel outcome trials.
Speaker: Professor J. Deanfield (London, GB)
Heart failure & diabetes: time for a more unified approach.
Speaker: Professor S. Anker (Berlin, DE)
Access the full session
Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)
Speakers:
Doctor D. Fitchett, Professor J. Deanfield, Doctor D. Fitchett, Professor N. Sattar, Professor J. Deanfield...
About the event
ESC 365 is supported by
